Open AccessLevosimendan for the Prevention of Acute Organ Dysfunction in Sepsis
Author(s) -
Anthony Gordon,
Gavin D. Perkins,
Mervyn Singer,
Daniel F. McAuley,
R. Orme,
Shalini Santhakumaran,
Alexina J. Mason,
Mary Cross,
Farah Al-Beidh,
Janis Best-Lane,
David Brealey,
Christopher Nutt,
James J. McNamee,
Henrik Reschreiter,
Andrew Breen,
Kathleen D. Liu,
Deborah Ashby
Publication year - 2016
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1609409
Subject(s) - levosimendan , medicine , sepsis , organ dysfunction , intensive care medicine , heart failure
Levosimendan is a calcium-sensitizing drug with inotropic and other properties that may improve outcomes in patients with sepsis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom